These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31586511)

  • 21. Re: Günter Janetschek. Laparoscopic partial nephrectomy for RCC: how can we avoid ischemic damage of the renal parenchyma? Eur Urol 2007;52:1303-5.
    Simone G; Guaglianone S; Gallucci M
    Eur Urol; 2008 Jun; 53(6):1302-3; author reply 1303-4. PubMed ID: 18222605
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019:76:136-7.
    Marconi L; Bensalah K; Bex A;
    Eur Urol; 2019 Jul; 76(1):e12-e13. PubMed ID: 30922689
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Robert J. Motzer, Pratik P. Rane, Todd L. Saretsky, et al. Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review. Eur Urol. Eur Urol. 2023;84:406-17.
    Gutiérrez Rojas AF; Fernández D; Diaz Ritter C
    Eur Urol; 2024 Mar; 85(3):e94. PubMed ID: 37802682
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.
    Sun M; Hansen J; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):e37-8. PubMed ID: 22172372
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Hendrik van Poppel, Luigi da Pozzo, Walter Albrecht, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.
    Ganesamoni R; Mavuduru R; Agarwal MM
    Eur Urol; 2011 Aug; 60(2):e9; author reply e10. PubMed ID: 21621322
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.
    Chesnut GT; Vertosick EA; Ehdaie B
    Eur Urol; 2020 Aug; 78(2):e65-e66. PubMed ID: 32386781
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?
    Mollica V; Rizzo A; Massari F
    Eur Urol Oncol; 2020 Aug; 3(4):559-560. PubMed ID: 32553708
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
    Kim JH; Chung BI
    Eur Urol; 2017 Nov; 72(5):e127-e128. PubMed ID: 28545840
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606-17.
    Marconi L; MacLennan S; Lam TBL; Canfield SE; Yuan Y; Omar MI; N'Dow J; Sylvester R
    Eur Urol; 2017 Sep; 72(3):e59-e60. PubMed ID: 28629586
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to Steven C. Campbell, Chalairat Suk-Ouichai, and Yun-Lin Ye's Words of Wisdom re: Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma. Antonelli A, Minervini A, Sandri M, et al. Eur Urol 2018;74:661-7 and 2019;75:198.
    Antonelli A; Minervini A; Capitanio U
    Eur Urol; 2019 Jul; 76(1):e17-e18. PubMed ID: 30711331
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Puppo P, Introini C, Calvi P, Naselli A. Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur Urol 2004;46:477-81.
    Carini M; Lapini A; Minervini A; Serni S
    Eur Urol; 2005 Feb; 47(2):265-6; author reply 266. PubMed ID: 15661426
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: Maxine Sun, Lorenzo Marconi, Tim Eisen, et al. Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. Eur Urol 2018;74:611-20: Systematic Review Findings on the Role of Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma.
    Hwang EC; Risk MC; Dahm P
    Eur Urol; 2019 Mar; 75(3):e67-e68. PubMed ID: 30466889
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to Lorenzo Marconi, Karim Bensalah, and Axel Bex's Letter to the Editor re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019;76:136-7.
    Verhagen PCMS; Boevé ER
    Eur Urol; 2019 Jul; 76(1):e14. PubMed ID: 30910344
    [No Abstract]   [Full Text] [Related]  

  • 35. Reply to Benjamin S. Simpson, Lina M. Carmona Echeverria, Joseph M. Norris, Hashim U. Ahmed, Caroline M. Moore, and Hayley C. Whitaker's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.
    Chesnut GT; Vickers AJ; Ehdaie B
    Eur Urol; 2020 Sep; 78(3):e108-e109. PubMed ID: 32522388
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Should Chromophobe Renal Cell Carcinoma Be Graded?
    Delahunt B; Samaratunga H; Egevad L
    Eur Urol; 2021 May; 79(5):e141-e142. PubMed ID: 33612375
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Steiner T, Knels R, Schubert J. Prognostic significance of tumor size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46;2004:327-30.
    Bogdanovic J
    Eur Urol; 2005 Feb; 47(2):266-7. PubMed ID: 15661427
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.
    Ghoreifi A; Djaladat H
    Eur Urol; 2023 Aug; 84(2):e53-e54. PubMed ID: 37149463
    [No Abstract]   [Full Text] [Related]  

  • 39. The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.
    Mason R; Kapoor A; Liu Z; Saarela O; Tanguay S; Jewett M; Finelli A; Lacombe L; Kawakami J; Moore R; Morash C; Black P; Rendon RA
    Urol Oncol; 2016 Nov; 34(11):486.e1-486.e7. PubMed ID: 27344410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274.
    Roussel E; Bertolo R; Ciccarese C; Marandino L; Marchioni M; Campi R; Albersen M;
    Eur Urol Oncol; 2024 Apr; 7(2):304-305. PubMed ID: 37981494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.